APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Huntington Disease Medications

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Huntington Disease Medications Industry Growth and Trends Forecast to 2032

Report ID 174000270128 December 2025103 pages

Choose your research edition.

Industry ResearchHuntington Disease Medications Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Huntington Disease Medications Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Huntington Disease Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Huntington Disease Medications Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Huntington Disease Medications Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Huntington Disease Medications market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Huntington Disease Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Huntington Disease Medications is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Huntington Disease Medications is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Huntington Disease Medications include Teva, Sandoz, Mylan, Zydus, Sun Pharmaceutical, Neurocrine Biosciences, Lupin, Hetero and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Huntington Disease Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Huntington Disease Medications market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Huntington Disease Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Huntington Disease Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Huntington Disease Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Huntington Disease Medications Market by Company

Teva

Sandoz

Mylan

Zydus

Sun Pharmaceutical

Neurocrine Biosciences

Lupin

Hetero

Dr. Reddy's Laboratories

Chartwell Pharmaceuticals

Bionpharma

Bausch Health

Apotex

Actavis Laboratories

Huntington Disease Medications Segment by Type

Deutetrabenazine

Tetrabenazine

Valbenazine

Others

Huntington Disease Medications Segment by Application

Hospital and Clinic

Pharmacy

Other

Huntington Disease Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington Disease Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Huntington Disease Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huntington Disease Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Huntington Disease Medications manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Huntington Disease Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Deutetrabenazine Table 2. Major Company of Tetrabenazine Table 3. Major Company of Valbenazine Table 4. Major Company of Others Table 5. Global Huntington Disease Medications Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Huntington Disease Medications Sales by Type (2021-2026) & (K Units) Table 7. Global Huntington Disease Medications Sales Market Share in Volume by Type (2021-2026) Table 8. Global Huntington Disease Medications Sales by Type (2021-2026) & (US$ Million) Table 9. Global Huntington Disease Medications Sales Market Share in Value by Type (2021-2026) Table 10. Global Huntington Disease Medications Price by Type (2021-2026) & (US$/Unit) Table 11. Global Huntington Disease Medications Sales by Type (2027-2032) & (K Units) Table 12. Global Huntington Disease Medications Sales Market Share in Volume by Type (2027-2032) Table 13. Global Huntington Disease Medications Sales by Type (2027-2032) & (US$ Million) Table 14. Global Huntington Disease Medications Sales Market Share in Value by Type (2027-2032) Table 15. Global Huntington Disease Medications Price by Type (2027-2032) & (US$/Unit) Table 16. North America Huntington Disease Medications Sales by Type (2021-2026) & (K Units) Table 17. North America Huntington Disease Medications Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Huntington Disease Medications Sales by Type (2021-2026) & (K Units) Table 19. Europe Huntington Disease Medications Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Huntington Disease Medications Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Huntington Disease Medications Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Huntington Disease Medications Sales by Type (2021-2026) & (K Units) Table 23. Latin America Huntington Disease Medications Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Huntington Disease Medications Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Huntington Disease Medications Sales by Type (2021-2026) & (US$ Million) Table 26. Huntington Disease Medications Industry Trends Table 27. Huntington Disease Medications Industry Drivers Table 28. Huntington Disease Medications Industry Opportunities and Challenges Table 29. Huntington Disease Medications Industry Restraints Table 30. Global Huntington Disease Medications Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Huntington Disease Medications Revenue Market Share by Company (2021-2026) Table 32. Global Huntington Disease Medications Sales by Company (2021-2026) & (K Units) Table 33. Global Huntington Disease Medications Sales Share by Company (2021-2026) Table 34. Global Huntington Disease Medications Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Huntington Disease Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Huntington Disease Medications Major Company Production Sites and Headquarters Table 37. Global Huntington Disease Medications Company, Product Type & Application Table 38. Global Huntington Disease Medications Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Huntington Disease Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Huntington Disease Medications Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Huntington Disease Medications Sales by Region (2021-2026) & (K Units) Table 43. Global Huntington Disease Medications Sales Market Share in Volume by Region (2021-2026) Table 44. Global Huntington Disease Medications Sales by Region (2021-2026) & (US$ Million) Table 45. Global Huntington Disease Medications Sales Market Share in Value by Region (2021-2026) Table 46. Global Huntington Disease Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Huntington Disease Medications Sales by Region (2027-2032) & (K Units) Table 48. Global Huntington Disease Medications Sales Market Share in Volume by Region (2027-2032) Table 49. Global Huntington Disease Medications Sales by Region (2027-2032) & (US$ Million) Table 50. Global Huntington Disease Medications Sales Market Share in Value by Region (2027-2032) Table 51. Global Huntington Disease Medications Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Huntington Disease Medications Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Huntington Disease Medications Sales by Application (2021-2026) & (K Units) Table 54. Global Huntington Disease Medications Sales Market Share in Volume by Application (2021-2026) Table 55. Global Huntington Disease Medications Sales by Application (2021-2026) & (US$ Million) Table 56. Global Huntington Disease Medications Sales Market Share in Value by Application (2021-2026) Table 57. Global Huntington Disease Medications Price by Application (2021-2026) & (US$/Unit) Table 58. Global Huntington Disease Medications Sales by Application (2027-2032) & (K Units) Table 59. Global Huntington Disease Medications Sales Market Share in Volume by Application (2027-2032) Table 60. Global Huntington Disease Medications Sales by Application (2027-2032) & (US$ Million) Table 61. Global Huntington Disease Medications Sales Market Share in Value by Application (2027-2032) Table 62. Global Huntington Disease Medications Price by Application (2027-2032) & (US$/Unit) Table 63. North America Huntington Disease Medications Sales by Application (2021-2026) & (K Units) Table 64. North America Huntington Disease Medications Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Huntington Disease Medications Sales by Application (2021-2026) & (K Units) Table 66. Europe Huntington Disease Medications Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Huntington Disease Medications Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Huntington Disease Medications Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Huntington Disease Medications Sales by Application (2021-2026) & (K Units) Table 70. Latin America Huntington Disease Medications Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Huntington Disease Medications Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Huntington Disease Medications Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva Huntington Disease Medications Product Portfolio Table 77. Teva Recent Development Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Sandoz Huntington Disease Medications Product Portfolio Table 82. Sandoz Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan Huntington Disease Medications Product Portfolio Table 87. Mylan Recent Development Table 88. Zydus Company Information Table 89. Zydus Business Overview Table 90. Zydus Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Zydus Huntington Disease Medications Product Portfolio Table 92. Zydus Recent Development Table 93. Sun Pharmaceutical Company Information Table 94. Sun Pharmaceutical Business Overview Table 95. Sun Pharmaceutical Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sun Pharmaceutical Huntington Disease Medications Product Portfolio Table 97. Sun Pharmaceutical Recent Development Table 98. Neurocrine Biosciences Company Information Table 99. Neurocrine Biosciences Business Overview Table 100. Neurocrine Biosciences Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Neurocrine Biosciences Huntington Disease Medications Product Portfolio Table 102. Neurocrine Biosciences Recent Development Table 103. Lupin Company Information Table 104. Lupin Business Overview Table 105. Lupin Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lupin Huntington Disease Medications Product Portfolio Table 107. Lupin Recent Development Table 108. Hetero Company Information Table 109. Hetero Business Overview Table 110. Hetero Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Hetero Huntington Disease Medications Product Portfolio Table 112. Hetero Recent Development Table 113. Dr. Reddy's Laboratories Company Information Table 114. Dr. Reddy's Laboratories Business Overview Table 115. Dr. Reddy's Laboratories Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolio Table 117. Dr. Reddy's Laboratories Recent Development Table 118. Chartwell Pharmaceuticals Company Information Table 119. Chartwell Pharmaceuticals Business Overview Table 120. Chartwell Pharmaceuticals Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolio Table 122. Chartwell Pharmaceuticals Recent Development Table 123. Bionpharma Company Information Table 124. Bionpharma Business Overview Table 125. Bionpharma Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Bionpharma Huntington Disease Medications Product Portfolio Table 127. Bionpharma Recent Development Table 128. Bausch Health Company Information Table 129. Bausch Health Business Overview Table 130. Bausch Health Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Bausch Health Huntington Disease Medications Product Portfolio Table 132. Bausch Health Recent Development Table 133. Apotex Company Information Table 134. Apotex Business Overview Table 135. Apotex Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Apotex Huntington Disease Medications Product Portfolio Table 137. Apotex Recent Development Table 138. Actavis Laboratories Company Information Table 139. Actavis Laboratories Business Overview Table 140. Actavis Laboratories Huntington Disease Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Actavis Laboratories Huntington Disease Medications Product Portfolio Table 142. Actavis Laboratories Recent Development Table 143. North America Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. North America Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 145. North America Huntington Disease Medications Sales Market Share by Country (2021-2026) Table 146. North America Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units) Table 147. North America Huntington Disease Medications Sales Market Share Forecast by Country (2027-2032) Table 148. North America Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Huntington Disease Medications Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Huntington Disease Medications Market Share by Country (2021-2026) Table 151. North America Huntington Disease Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Huntington Disease Medications Market Share Forecast by Country (2027-2032) Table 153. Europe Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Europe Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 155. Europe Huntington Disease Medications Sales Market Share by Country (2021-2026) Table 156. Europe Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units) Table 157. Europe Huntington Disease Medications Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Huntington Disease Medications Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Huntington Disease Medications Market Share by Country (2021-2026) Table 161. Europe Huntington Disease Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Huntington Disease Medications Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 165. Asia-Pacific Huntington Disease Medications Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units) Table 167. Asia-Pacific Huntington Disease Medications Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Huntington Disease Medications Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Huntington Disease Medications Market Share by Country (2021-2026) Table 171. Asia-Pacific Huntington Disease Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Huntington Disease Medications Market Share Forecast by Country (2027-2032) Table 173. Latin America Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Latin America Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 175. Latin America Huntington Disease Medications Sales Market Share by Country (2021-2026) Table 176. Latin America Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units) Table 177. Latin America Huntington Disease Medications Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Huntington Disease Medications Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Huntington Disease Medications Market Share by Country (2021-2026) Table 181. Latin America Huntington Disease Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Huntington Disease Medications Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Huntington Disease Medications Sales by Country (2021-2026) & (K Units) Table 185. Middle East and Africa Huntington Disease Medications Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Huntington Disease Medications Sales Forecast by Country (2027-2032) & (K Units) Table 187. Middle East and Africa Huntington Disease Medications Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Huntington Disease Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Huntington Disease Medications Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Huntington Disease Medications Market Share by Country (2021-2026) Table 191. Middle East and Africa Huntington Disease Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Huntington Disease Medications Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Huntington Disease Medications Distributors List Table 196. Huntington Disease Medications Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Huntington Disease Medications Image Figure 2. Global Huntington Disease Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Huntington Disease Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Huntington Disease Medications Sales (2021-2032) & (K Units) Figure 5. Deutetrabenazine Image Figure 6. Global Deutetrabenazine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tetrabenazine Image Figure 8. Global Tetrabenazine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Valbenazine Image Figure 10. Global Valbenazine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Huntington Disease Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Huntington Disease Medications Market Share by Type 2025 VS 2032 Figure 15. North America Huntington Disease Medications Sales Market Share in Volume by Type in 2025 Figure 16. North America Huntington Disease Medications Sales Market Share in Value by Type in 2025 Figure 17. Europe Huntington Disease Medications Sales Market Share in Volume by Type in 2025 Figure 18. Europe Huntington Disease Medications Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Huntington Disease Medications Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Huntington Disease Medications Sales Market Share in Value by Type in 2025 Figure 21. Latin America Huntington Disease Medications Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Huntington Disease Medications Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Huntington Disease Medications Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Huntington Disease Medications Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Huntington Disease Medications Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital and Clinic Image Figure 28. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Pharmacy Image Figure 30. Global Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Huntington Disease Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Huntington Disease Medications Market Share by Application 2025 VS 2032 Figure 35. North America Huntington Disease Medications Sales Market Share in Volume by Application in 2025 Figure 36. North America Huntington Disease Medications Sales Market Share in Value by Application in 2025 Figure 37. Europe Huntington Disease Medications Sales Market Share in Volume by Application in 2025 Figure 38. Europe Huntington Disease Medications Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Huntington Disease Medications Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Huntington Disease Medications Sales Market Share in Value by Application in 2025 Figure 41. Latin America Huntington Disease Medications Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Huntington Disease Medications Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Huntington Disease Medications Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Huntington Disease Medications Sales Market Share in Value by Application in 2025 Figure 45. North America Huntington Disease Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Huntington Disease Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Huntington Disease Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Huntington Disease Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Huntington Disease Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Huntington Disease Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Huntington Disease Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Huntington Disease Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Huntington Disease Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Huntington Disease Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Huntington Disease Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Huntington Disease Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Huntington Disease Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Huntington Disease Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Huntington Disease Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Huntington Disease Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Huntington Disease Medications Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Huntington Disease Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Huntington Disease Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Huntington Disease Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Huntington Disease Medications Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Huntington Disease Medications Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Deutetrabenazine
  • Tetrabenazine
  • Valbenazine
  • Others
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Zydus
  • Sun Pharmaceutical
  • Neurocrine Biosciences
  • Lupin
  • Hetero
  • Dr. Reddy's Laboratories
  • Chartwell Pharmaceuticals
  • Bionpharma
  • Bausch Health
  • Apotex
  • Actavis Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Huntington Disease Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Huntington Disease Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Huntington Disease Medications Market by Type
  6. 1.3.1 Deutetrabenazine
  7. 1.3.2 Tetrabenazine
  8. 1.3.3 Valbenazine
  9. 1.3.4 Others
  10. 1.4 Global Huntington Disease Medications Market Size by Type
  11. 1.4.1 Global Huntington Disease Medications Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Huntington Disease Medications Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Huntington Disease Medications Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Huntington Disease Medications Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Huntington Disease Medications Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Huntington Disease Medications Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Huntington Disease Medications Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Huntington Disease Medications Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Huntington Disease Medications Industry Trends
  2. 2.2 Huntington Disease Medications Industry Drivers
  3. 2.3 Huntington Disease Medications Industry Opportunities and Challenges
  4. 2.4 Huntington Disease Medications Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Huntington Disease Medications Revenue (2021-2026)
  2. 3.2 Global Top Players by Huntington Disease Medications Sales (2021-2026)
  3. 3.3 Global Top Players by Huntington Disease Medications Price (2021-2026)
  4. 3.4 Global Huntington Disease Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Huntington Disease Medications Major Company Production Sites & Headquarters
  6. 3.6 Global Huntington Disease Medications Company, Product Type & Application
  7. 3.7 Global Huntington Disease Medications Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Huntington Disease Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Huntington Disease Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Huntington Disease Medications Tier 1, Tier 2, and Tier 3
4 Huntington Disease Medications Regional Status and Outlook
  1. 4.1 Global Huntington Disease Medications Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Huntington Disease Medications Historic Market Size by Region
  3. 4.2.1 Global Huntington Disease Medications Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Huntington Disease Medications Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Huntington Disease Medications Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Huntington Disease Medications Forecasted Market Size by Region
  7. 4.3.1 Global Huntington Disease Medications Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Huntington Disease Medications Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Huntington Disease Medications Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Huntington Disease Medications by Application
  1. 5.1 Huntington Disease Medications Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Huntington Disease Medications Market Size by Application
  6. 5.2.1 Global Huntington Disease Medications Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Huntington Disease Medications Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Huntington Disease Medications Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Huntington Disease Medications Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Huntington Disease Medications Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Huntington Disease Medications Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Huntington Disease Medications Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Huntington Disease Medications Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Huntington Disease Medications Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Huntington Disease Medications Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Huntington Disease Medications Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Zydus
  20. 6.4.1 Zydus Company Information
  21. 6.4.2 Zydus Business Overview
  22. 6.4.3 Zydus Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zydus Huntington Disease Medications Product Portfolio
  24. 6.4.5 Zydus Recent Developments
  25. 6.5 Sun Pharmaceutical
  26. 6.5.1 Sun Pharmaceutical Company Information
  27. 6.5.2 Sun Pharmaceutical Business Overview
  28. 6.5.3 Sun Pharmaceutical Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sun Pharmaceutical Huntington Disease Medications Product Portfolio
  30. 6.5.5 Sun Pharmaceutical Recent Developments
  31. 6.6 Neurocrine Biosciences
  32. 6.6.1 Neurocrine Biosciences Company Information
  33. 6.6.2 Neurocrine Biosciences Business Overview
  34. 6.6.3 Neurocrine Biosciences Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Neurocrine Biosciences Huntington Disease Medications Product Portfolio
  36. 6.6.5 Neurocrine Biosciences Recent Developments
  37. 6.7 Lupin
  38. 6.7.1 Lupin Company Information
  39. 6.7.2 Lupin Business Overview
  40. 6.7.3 Lupin Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lupin Huntington Disease Medications Product Portfolio
  42. 6.7.5 Lupin Recent Developments
  43. 6.8 Hetero
  44. 6.8.1 Hetero Company Information
  45. 6.8.2 Hetero Business Overview
  46. 6.8.3 Hetero Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hetero Huntington Disease Medications Product Portfolio
  48. 6.8.5 Hetero Recent Developments
  49. 6.9 Dr. Reddy's Laboratories
  50. 6.9.1 Dr. Reddy's Laboratories Company Information
  51. 6.9.2 Dr. Reddy's Laboratories Business Overview
  52. 6.9.3 Dr. Reddy's Laboratories Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Dr. Reddy's Laboratories Huntington Disease Medications Product Portfolio
  54. 6.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 6.10 Chartwell Pharmaceuticals
  56. 6.10.1 Chartwell Pharmaceuticals Company Information
  57. 6.10.2 Chartwell Pharmaceuticals Business Overview
  58. 6.10.3 Chartwell Pharmaceuticals Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Chartwell Pharmaceuticals Huntington Disease Medications Product Portfolio
  60. 6.10.5 Chartwell Pharmaceuticals Recent Developments
  61. 6.11 Bionpharma
  62. 6.11.1 Bionpharma Company Information
  63. 6.11.2 Bionpharma Business Overview
  64. 6.11.3 Bionpharma Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Bionpharma Huntington Disease Medications Product Portfolio
  66. 6.11.5 Bionpharma Recent Developments
  67. 6.12 Bausch Health
  68. 6.12.1 Bausch Health Company Information
  69. 6.12.2 Bausch Health Business Overview
  70. 6.12.3 Bausch Health Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bausch Health Huntington Disease Medications Product Portfolio
  72. 6.12.5 Bausch Health Recent Developments
  73. 6.13 Apotex
  74. 6.13.1 Apotex Company Information
  75. 6.13.2 Apotex Business Overview
  76. 6.13.3 Apotex Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Apotex Huntington Disease Medications Product Portfolio
  78. 6.13.5 Apotex Recent Developments
  79. 6.14 Actavis Laboratories
  80. 6.14.1 Actavis Laboratories Company Information
  81. 6.14.2 Actavis Laboratories Business Overview
  82. 6.14.3 Actavis Laboratories Huntington Disease Medications Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Actavis Laboratories Huntington Disease Medications Product Portfolio
  84. 6.14.5 Actavis Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Huntington Disease Medications Sales by Country
  2. 7.1.1 North America Huntington Disease Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Huntington Disease Medications Sales by Country (2021-2026)
  4. 7.1.3 North America Huntington Disease Medications Sales Forecast by Country (2027-2032)
  5. 7.2 North America Huntington Disease Medications Market Size by Country
  6. 7.2.1 North America Huntington Disease Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Huntington Disease Medications Market Size by Country (2021-2026)
  8. 7.2.3 North America Huntington Disease Medications Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Huntington Disease Medications Sales by Country
  2. 8.1.1 Europe Huntington Disease Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Huntington Disease Medications Sales by Country (2021-2026)
  4. 8.1.3 Europe Huntington Disease Medications Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Huntington Disease Medications Market Size by Country
  6. 8.2.1 Europe Huntington Disease Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Huntington Disease Medications Market Size by Country (2021-2026)
  8. 8.2.3 Europe Huntington Disease Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Huntington Disease Medications Sales by Country
  2. 9.1.1 Asia-Pacific Huntington Disease Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Huntington Disease Medications Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Huntington Disease Medications Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Huntington Disease Medications Market Size by Country
  6. 9.2.1 Asia-Pacific Huntington Disease Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Huntington Disease Medications Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Huntington Disease Medications Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Huntington Disease Medications Sales by Country
  2. 10.1.1 South America Huntington Disease Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Huntington Disease Medications Sales by Country (2021-2026)
  4. 10.1.3 South America Huntington Disease Medications Sales Forecast by Country (2027-2032)
  5. 10.2 South America Huntington Disease Medications Market Size by Country
  6. 10.2.1 South America Huntington Disease Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Huntington Disease Medications Market Size by Country (2021-2026)
  8. 10.2.3 South America Huntington Disease Medications Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Huntington Disease Medications Sales by Country
  2. 11.1.1 Middle East and Africa Huntington Disease Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Huntington Disease Medications Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Huntington Disease Medications Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Huntington Disease Medications Market Size by Country
  6. 11.2.1 Middle East and Africa Huntington Disease Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Huntington Disease Medications Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Huntington Disease Medications Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Huntington Disease Medications Value Chain Analysis
  2. 12.1.1 Huntington Disease Medications Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Huntington Disease Medications Production Mode & Process
  7. 12.2 Huntington Disease Medications Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Huntington Disease Medications Distributors
  10. 12.2.3 Huntington Disease Medications Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst